CHA AI Healthkare Signs 52.6 Billion KRW 5-Year Supply Contract with Nissho Medical, Expects 720% Revenue Boost
CHA AI Healthkare has signed a 5-year long-term product supply contract with Nissho Medical valued at 52.6 billion KRW. This massive contract represents 720% of last year's revenue of 7.3 billion KRW, promising stable revenue growth over the next five years.
Payment terms include a 20% advance and 80% balance. The counterparty Nissho Medical was acquired by a private equity fund in which CHA AI Healthkare participates as a limited partner, raising potential related-party concerns.
While the contract signals a significant revenue boost, investors should monitor execution risks and transaction transparency given the indirect relationship.
[AI Summary]This 52.6 billion KRW supply contract provides over 7x revenue potential, but governance risks from the private equity-linked counterparty warrant caution.